This apparent difference in the mode of tumour acceleration is interesting as CD2-Runx2 mice harbour an expanded population of transformation-prone thymocytes, which has no parallel in CD2-MYC mice, most of which remain healthy with no obvious abnormality [8], [16], [43]. This evidence concerns the gene MYC and neoplasm.